Location: Seattle, Washinton DC, Geneva
NOTE: This position is contingent upon donor funding.
PATH is a global organization that works to accelerate health equity by bringing together public institutions, businesses, social enterprises, and investors to solve the world’s most pressing health challenges. With expertise in science, health, economics, technology, advocacy, and dozens of other specialties, PATH develops and scales solutions—including vaccines, drugs, devices, diagnostics, and innovative approaches to strengthening health systems worldwide.
PATH is seeking a Market Dynamics Officer as the technical lead for the organization’s market dynamics contributions to the third output of an anticipated multi-year Unitaid funded project. The project’s goals are to accelerate the adoption and scale up of Intermittent Preventive Treatment in infants (IPTi) in moderate-to-high transmission settings in sub-Saharan Africa. IPTi is the administration of antimalarial drugs to infants at defined intervals to provide personal protection against malaria. Under current WHO guidelines, the drug sulfadoxine-pyrimethamine (SP) is delivered to infants at approximately 2, 3, and 9 months of age during routine immunization services. IPTi is safe, cost-effective, well accepted by health workers and communities, and has been found to provide significant protection against clinical malaria and anemia. Despite the WHO recommendations, uptake of IPTi has been limited to date.
The Market Dynamics Officer will lead the market shaping activities and work to address the critical access barriers which affect IPTi delivery across the selected countries in the project. This role will represent PATH and will collaborate with National Malaria Control Programs (NMCP), regulatory bodies, procurement agencies, researchers, and other critical national stakeholders to ensure pathways for transition & scale-up of the project.
Specific responsibilities include:
- Develop a sound understanding and play an integral role in regional knowledge sharing of the political landscape, malaria situation, funding landscape, regulatory pathways, implementation strategies, and risks, barriers and opportunities to shape the market for SP to catalyze IPTi delivery.
- Design and oversee implementation of a proof of concept for sustainable procurement, financing, market introduction, and continued supply of IPTi, and support ongoing monitoring of the market.
- Build analytical tools and modeling approaches to estimate the market size and future demand for IPTi.
- Model total costs of SP sourcing/production under different scenarios of scale in project focus countries.
- Support and provide technical expertise to NMCPs, country teams, and national government partners for protocol development and execution of feasibility studies, cost-effectiveness studies, and budget-impact analyses to inform policy adoption decisions for new tools.
- In collaboration with country teams, Ministry of Health (MOH), NMCPs, researchers and, other relevant partners, help keep an updated a roadmap for policy adoption, mobilizing funding, procurement processes, distribution and ensuring availability of SP in target countries across the region.
- As needed, collaborate with manufacturers to monitor market stability, share demand expectations, and ensure uninterrupted quality assured supply of SP.
- As appropriate, support the pilot introduction of SP in IPTi delivery, including support to NMCPs to provide technical guidance on protocols, attending country and regional coordination meetings, and the sharing of relevant data, documents, information, and disseminating study findings to key
- Contribute to overarching project goals of data sharing and disseminating learnings across project countries
- Assist the global support and country project teams (finance, external relations, and access) in developing monthly internal reports, bi-annual reports to the donor, including progress against project targets, measuring impact of trainings and availability of SP in treatment settings, as well as ad hoc programmatic reporting as
- Willingness to travel domestically and internationally (up to 25%).